Short answer
DENTSPLY SIRONA Inc (XRAY) filed an 8-K current report with the SEC on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 fiscal 2026 results for the quarter ended September 30, 2026.
DENTSPLY SIRONA Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 fiscal 2026 results for the quarter ended September 30, 2026
- Press release Exhibit 99.1 contains the financial results and management commentary
- Results release provides the basis for assessing revenue, profitability, guidance and outlook changes
Item EX-99.1 · Exhibit EX-99.1
- Q3 sales $836M, down 7.6% YoY, with declines across three core segments; Wellspect grew 10.1%
- Adjusted EPS $0.29, down 29.4%, and adjusted EBITDA margin 17.3% vs 18.4%, indicating weaker operating leverage
- $39M inventory-estimate benefit boosted gross profit and adjusted net income, creating a nonrecurring comparison benefit
- Free cash flow fell to $0M from $40M, while cash declined to $195M and debt remained $2.2B
- FY2026 outlook reset to approximately $3.5B sales and adjusted EPS $1.20 to $1.30, excluding a $0.17 tariff-refund benefit
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other DENTSPLY SIRONA Inc 8-K filings
Get the next XRAY 8-K as it lands
Follow XRAY for push alerts, or ask the research agent what this filing means.